These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 8708809)
1. Perimenopausal and postmenopausal hormone replacement therapy: Part 1. An update of the literature on benefits and risks. Solomon D J Nurse Midwifery; 1996; 41(3):228-9. PubMed ID: 8708809 [No Abstract] [Full Text] [Related]
2. Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution. Genazzani AR; Gambacciani M Gynecol Endocrinol; 2006 Mar; 22(3):145-50. PubMed ID: 16835076 [TBL] [Abstract][Full Text] [Related]
3. [Risks and benefits of postmenopausal hormone replacement therapy]. Szántó F Orv Hetil; 1998 Nov; 139(44):2639-42. PubMed ID: 9842237 [TBL] [Abstract][Full Text] [Related]
4. Approach to the perimenopausal patient. French L J Fam Pract; 2002 Mar; 51(3):271-6. PubMed ID: 11978240 [No Abstract] [Full Text] [Related]
5. Prognostic features of menopausal and postmenopausal applicants for life insurance. Schiefeling M J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866 [TBL] [Abstract][Full Text] [Related]
9. [Are hormones dangerous? Physicians as well as patients need more information about postmenopausal hormone therapy]. Ejeby K; Högland A; Eggens I; Engfeldt P Lakartidningen; 1997 Mar; 94(12):1080-3. PubMed ID: 9121241 [No Abstract] [Full Text] [Related]
10. Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women. Romero M Adv Nurse Pract; 2002 Nov; 10(11):47-8, 51-2. PubMed ID: 12478948 [No Abstract] [Full Text] [Related]
11. [Hormone therapy in climacteric. Varying research results on risks and benefits]. Magnusson C; Persson I Lakartidningen; 1997 Mar; 94(13):1176-9. PubMed ID: 9148053 [No Abstract] [Full Text] [Related]
12. Hormone replacement therapy: all a woman could desire? Adams S J Fam Health Care; 2002; 12(4):105-6. PubMed ID: 12416018 [TBL] [Abstract][Full Text] [Related]
13. [Cerebral risks in hormone replacement therapy in postmenopausal women. WHI Study]. Müllges W Internist (Berl); 2004 Feb; 45(2):228-30. PubMed ID: 14991166 [No Abstract] [Full Text] [Related]
14. [Effect of long-term hormone substitution therapy on serum TSH level in postmenopausal women]. Foth D; Römer T Zentralbl Gynakol; 1999; 121(10):495-8. PubMed ID: 10573824 [TBL] [Abstract][Full Text] [Related]
16. [Changes of nitric oxide and endothelin plasma levels and effects of hormone replacement therapy in postmenopausal women]. Lai A; Zhang J; Ding L Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):222-4. PubMed ID: 11776165 [TBL] [Abstract][Full Text] [Related]
17. Managing the transition from oral contraceptives to hormone replacement therapy. Burkman RT Am J Manag Care; 2001 Nov; 7(18 Suppl):S575-9. PubMed ID: 11727396 [TBL] [Abstract][Full Text] [Related]
18. Update: the latest on hormone replacement therapy. Packin GS J Am Osteopath Assoc; 2000 Oct; 100(10 Su Pt 1):S2-5. PubMed ID: 11105456 [TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy: current concerns and considerations. Carroll DG; Noble SL Am J Manag Care; 2002 Jul; 8(7):663-75; quiz 676-8. PubMed ID: 12125806 [TBL] [Abstract][Full Text] [Related]
20. The importance of patient education in improving compliance. Sturdee DW Climacteric; 2000 Dec; 3 Suppl 2():9-13. PubMed ID: 11379385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]